Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
-
Tomasz Dziedzic
Abstract
Background and purpose: Several studies show a link between microalbuminuria and markers of inflammation. Increased urine albumin excretion accompanies acute ischaemic stroke. The mechanisms responsible for microalbuminuria in acute stroke patients remain unclear. The goal of this study was to determine if there is a relationship between urine albumin excretion and interleukin-6, a key mediator of acute phase reaction. Methods: Nineteen acute ischaemic stroke patients and 13 controls matched for age, sex and cardiovascular risk factors were included. Serum interleukin-6 level was measured on the 2nd day of stroke at 06:00 am, 10:00 am, 06:00 pm and 10:00 pm using ELISA method. Urine albumin excretion was determined using immunonephelometric method. Results: Interleukin-6 level and urine albumin excretion were significantly higher in stroke patients than in controls. There was a significant correlation between interleukin-6 level and urine albumin excretion in stroke patients (R=−0.60 at 06:00 am; R=−0.49 at 10:00 am; R=−0.64 at 06:00 pm; R=−0.54 at 10:00 pm) but not in controls. Conclusions: Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6.
Copyright © 2004 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
- Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
- Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
- Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
- Antioxidants in patients with hyperthyroidism
- Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
- Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
- Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
- Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
- Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
- Diagnostic use of cerebral and extracerebral oxysterols
- Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
- The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
- Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
- Testing and validating a homogeneous immunometric assay for interference
- Linearity evaluation of analytical methods that count particles
- Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
- Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
- Distribution of low-density lipoprotein particle size in healthy Korean adult males
- Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
- The phenomenon of regression-toward-the-mean
- Error messages when calculating chi-square statistics with Microsoft EXCEL®
- Meetings and Awards
Articles in the same Issue
- Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
- Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
- Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
- Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
- Antioxidants in patients with hyperthyroidism
- Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
- Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
- Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
- Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
- Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
- Diagnostic use of cerebral and extracerebral oxysterols
- Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
- The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
- Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
- Testing and validating a homogeneous immunometric assay for interference
- Linearity evaluation of analytical methods that count particles
- Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
- Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
- Distribution of low-density lipoprotein particle size in healthy Korean adult males
- Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
- The phenomenon of regression-toward-the-mean
- Error messages when calculating chi-square statistics with Microsoft EXCEL®
- Meetings and Awards